DE1436140U - - Google Patents

Info

Publication number
DE1436140U
DE1436140U DENDAT1436140D DE1436140DU DE1436140U DE 1436140 U DE1436140 U DE 1436140U DE NDAT1436140 D DENDAT1436140 D DE NDAT1436140D DE 1436140D U DE1436140D U DE 1436140DU DE 1436140 U DE1436140 U DE 1436140U
Authority
DE
Germany
Prior art keywords
ird
velrlngdrt
ufdßsum
uchsun
tteprfiche
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1436140D
Other languages
German (de)
English (en)
Publication of DE1436140U publication Critical patent/DE1436140U/de
Active legal-status Critical Current

Links

Landscapes

  • Hybrid Cells (AREA)
  • Primary Cells (AREA)
DENDAT1436140D Active DE1436140U (OSRAM)

Publications (1)

Publication Number Publication Date
DE1436140U true DE1436140U (OSRAM)

Family

ID=744865

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1436140D Active DE1436140U (OSRAM)

Country Status (1)

Country Link
DE (1) DE1436140U (OSRAM)

Similar Documents

Publication Publication Date Title
EP0702560B1 (en) Immunologic enhancement with intermittent interleukin-2 therapy
Laurence et al. Acquired immunodeficiency without evidence of infection with human immunodeficiency virus types 1 and 2
Lane et al. Anti-retroviral effects of interferon-α in AIDS-associated Kaposi's sarcoma
Krown et al. Efficacy of low-dose interferon with antiretroviral therapy in Kaposi's sarcoma: a randomized phase II AIDS clinical trials group study
Israël-Biet et al. Tumor necrosis factor production in HIV-seropositive subjects. Relationship with lung opportunistic infections and HIV expression in alveolar macrophages
DE1436140U (OSRAM)
US5696079A (en) Immunologic enhancement with intermittent interleukin-2 therapy
Khanlou et al. Co-administration of atazanavir with proton-pump inhibitors and H2 blockers
Berglund et al. Combined treatment of symptomatic human immunodeficiency virus type 1 infection with native interferon-α and zidovudine
Hewitt et al. Pharmacokinetics and pharmacodynamics of granulocyte-macrophage colony-stimulating factor and zidovudine in patients with AIDS and severe AIDS-related complex
CN1281623C (zh) 抗病毒活性的人α干扰素衍生物
CN1943564A (zh) 吲达帕胺缓释片及其制备方法
DE1491718U (OSRAM)
WO2019107986A1 (ko) 피마살탄을 포함하는 약학적 조성물
CN213197198U (zh) 一种用于钢结构加工的夹紧设备
OHASHI et al. Effects of interferon-α on a reduced release of interleukin-8 from latently HIV-1-infected monocytic cell line U937 cells
CN1145592C (zh) 一种硅酸钙绝热制品及其制备方法
DE1409138U (OSRAM)
AP132A (en) Improved formulation of low-dose interferon alpha.
Lefkowitz et al. Cocaine inhibits production of murine hepatitis virus by peritoneal macrophages in vitro
Chuenchitra et al. Serum levels of MIP-1beta and RANTES in HIV-1 subtype CRF01_AE infected patients with different rates of disease progression
CN1435178A (zh) 含中药环维黄杨星d的渗透泵控释制剂及其制备方法
CN1502339A (zh) 稀土杂多酸盐（蓝）类抗艾滋病药物及其制备方法
CN1108815C (zh) 复方α干扰素含片及其制备方法
Yamauchi et al. Dynamic Fatigue Behavior of Ceramics at Elevated Temperatures